Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

TEST OF HIV-SPECIFIC T LYMPHOCYTE FUNCTION THAT DETECTS EXPOSURE TO HIV ANTIGENS AND POSSIBLY EARLY HIV INFECTION

  • Read more about TEST OF HIV-SPECIFIC T LYMPHOCYTE FUNCTION THAT DETECTS EXPOSURE TO HIV ANTIGENS AND POSSIBLY EARLY HIV INFECTION
US Application 07/882,078
Filed on 1992-05-14

ANTI-HUMAN OVARIAN CANCER IMMUNOTOXINS AND METHODS OF USE THEREOF

  • Read more about ANTI-HUMAN OVARIAN CANCER IMMUNOTOXINS AND METHODS OF USE THEREOF
US Patent 4,958,009
Filed on 1987-07-06

BISPECIFIC ANTIBODY ENHANCEMENT OF IMMUNIZATION

  • Read more about BISPECIFIC ANTIBODY ENHANCEMENT OF IMMUNIZATION
US Application 07/794,638
Filed on 1991-11-18

PROCESS OF SEPARATING THE DIASTEREOMERS OF (6R,6S)-5,6,7,8-TETRA- HYDROFOLIC ACID DERIVATIVES

  • Read more about PROCESS OF SEPARATING THE DIASTEREOMERS OF (6R,6S)-5,6,7,8-TETRA- HYDROFOLIC ACID DERIVATIVES
US Patent 5,698,693
Filed on 1992-11-16

METHOD FOR IDENTIFYING AND EXPRESSING PROTEINS THAT RECOGNIZE AND ADHERE TO SPECIFIC PROBES

  • Read more about METHOD FOR IDENTIFYING AND EXPRESSING PROTEINS THAT RECOGNIZE AND ADHERE TO SPECIFIC PROBES
US Patent 5,316,922
Filed on 1992-04-15

ANTINEOPLASTIC, SYSTEM -L SPECIFIC AMINO ACID NITROGEN MUSTARDS

  • Read more about ANTINEOPLASTIC, SYSTEM -L SPECIFIC AMINO ACID NITROGEN MUSTARDS
US Patent 5,284,774
Filed on 1991-11-15

METHOD FOR MEASURING TYPE IV COLLAGENASE (AS AMENDED)

  • Read more about METHOD FOR MEASURING TYPE IV COLLAGENASE (AS AMENDED)
US Patent 5,869,277
Filed on 1991-11-08

PRODUCTION OF HUMAN T-CELL LEUKEMIA (LYMPHOTROPIC) RETROVIRUS (HTLV-1) ENVELOPE PROTEIN FRAGMENTS IN BACTERIAL AND USE IN SEROEP...

  • Read more about PRODUCTION OF HUMAN T-CELL LEUKEMIA (LYMPHOTROPIC) RETROVIRUS (HTLV-1) ENVELOPE PROTEIN FRAGMENTS IN BACTERIAL AND USE IN SEROEP...
US Application 07/784,915
Filed on 1991-10-30

PURIFIED TRANSFORMING GROWTH FACTOR BETA (TGF-B)

  • Read more about PURIFIED TRANSFORMING GROWTH FACTOR BETA (TGF-B)
US Patent 5,104,977
Filed on 1989-02-08

PURIFIED TRANSFORMING GROWTH FACTOR BETA (TGF-B)

  • Read more about PURIFIED TRANSFORMING GROWTH FACTOR BETA (TGF-B)
US Application 07/816,563
Filed on 1992-01-03

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1622
  • Page 1623
  • Page 1624
  • Page 1625
  • Page 1626
  • Page 1627
  • Page 1628
  • Page 1629
  • Page 1630
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health